loading

Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
0.172 1.028 - -
Operating Expenses
13.79%
10.51
12.19 15.99 11.80 12.52
Interest Income/Expense
7.00%
0.877
0.943 1.124 1.337 1.276
Benefits Costs and Expenses
13.06%
11.22
12.91 - - -
Costs And Expenses
13.06%
11.22
12.91 - - -
Depreciation and Amortization
4.38%
0.24
0.251 0.266 0.259 0.255
Operating Income/Loss
12.55%
-10.51
-12.01 -14.96 -11.80 -12.52
Income/Loss From Continuing Operations Before Tax
11.89%
-11.22
-12.74 -15.72 -12.72 -13.36
Income/Loss From Continuing Operations After Tax
11.89%
-11.22
-12.74 -15.72 -12.72 -13.36
Net Income/Loss
11.89%
-11.22
-12.74 -15.72 -12.72 -13.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
17.21%
-4.532
-5.474 -6.775 -5.939 -6.556
Basic Average Shares
9.28%
36.54
33.44 -27.04 28.84 26.32
Diluted Average Shares
9.28%
36.54
33.44 -27.04 28.84 26.32
Basic Earnings Per Share
18.18%
-0.18
-0.22 -0.27 -0.24 -0.26
Diluted Earnings Per Share
18.18%
-0.18
-0.22 -0.27 -0.24 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.73
price up icon 0.79%
$84.79
price up icon 0.80%
$24.86
price down icon 7.88%
$103.16
price down icon 1.99%
$133.77
price up icon 1.19%
biotechnology ONC
$298.86
price down icon 3.37%
Capitalizzazione:     |  Volume (24 ore):